2005
Dec.26
Comprehensive Bio-related Business Tie-up between livedoor Group and TRANS GENIC INC. Joint Investment for Bio Funds
Nov.14
Conclusion of Management Agreement with livedoor Securities Co., Ltd.
Nov.07
Agreement Concluded on business tie-up between JSW-Research and TRANS GENIC
Oct.24
Agreement concluded on Business Tie-up between Protosera and TRANS GENIC
Oct.03
Agreement Concluded on R & D Support Service-related Business Tie-up between Hitachi and TRANS GENIC
Sep.29
Agreement Concluded with Mitsubishi Kagaku Institute of Life Sciences to License Right to Use Gene Knockout Mice
Sep.22
Obtaining Patents on Knockout Mouse
Aug.26
Recognition of Research as Support Project for Establishment of Business-Academia Collaborative New Industries
Aug.25
Release of DNA Microarray Kit for Assessment of Chemical Agent
Aug.16
Changing the Status of a Main Shareholder
Jul.06
Operation of Kobe Laboratory
Jun.27
Patent Application for New Target Drug Screening
May 30
Conclusion of Feasibility Study Agreement with Vital Star
May 16
Notice of Simplified Merger with EU GENE LTD.
Apr.28
Introducing new products;"The Manual for Reproductive Engineering Techniques in Mice" (CD-ROM)
Apr.26
Publication of Study Producing High-Affinity Antibody Using Ganp Gene-Transgenic Mouse
Apr.26
Notice of Conclusion of Basic Agency Agreement with Charles River Laboratories Japan, Inc. regarding Distribution of Knockout Mice
Apr.18
Highly Sensitive Immunological Assay System for Cancer Diagnosis Using Urine Samples: The Development of In Vitro Diagnostic Products
Feb.15
Completion and Renewed Conclusion of the z`greement on the Exclusive Provision of Information about Gene Knockout Micezơith Sumitomo Pharmaceuticals Co., Ltd.
Feb.08
Opening of Kobe Office
Jan.24
Patent Application for Assay System for Cancer Diagnosis Using Urine Samples
>>
2010
>>
2009
>>
2008
>>
2007
>>
2006
>>
2005
>>
2004
>>
2003
>>
2002
